Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001; Massachusetts Medical Society; Volume: 345; Issue: 12 Linguagem: Inglês
10.1056/nejmoa011303
ISSN1533-4406
AutoresEdmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomás Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itamar Raz,
Tópico(s)Hormonal Regulation and Hypertension
ResumoIt is unknown whether either the angiotensin-II–receptor blocker irbesartan or the calcium-channel blocker amlodipine slows the progression of nephropathy in patients with type 2 diabetes independently of its capacity to lower the systemic blood pressure.
Referência(s)